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The aim of this study was to investigate if the alternative in vivo model Galleria mellonella can be used (i) to
determine differences in pathogenicity of amphotericin B (AMB) resistant and susceptible A. terreus isolates, (ii) to
evaluate AMB efficacy in vivo (iii) and to correlate outcome to in vitro susceptibility data. Larvae were infected with 2 A.
terreus AMB resistant (ATR) and 3 AMB susceptible (ATS) isolates and survival rates were correlated to physiological
attributes and killing ability of larval haemocytes. Additionally, infected larvae were treated with different
concentrations of L-AMB. Haemocyte density were ascertained to evaluate the influence of L-AMB on the larval immune
cells. Larvae were sensitive to A. terreus infection in an inoculum-size and temperature dependent manner. In vitro
susceptibility to L-AMB correlated with in vivo outcome of antifungal treatment, defining an AMB susceptible strain
cluster of A. terreus. Susceptibility to L-AMB increased virulence potential in the larval model, but this increase was also
in accordance with faster growth and less damage caused by larval haemocytes. L-AMB treatment primed the larval
immune response by increasing haemocyte density. G. mellonella provides a convenient model for the in vivo screening
of A. terreus virulence and treatment options, contributing to the generation of a hypothesis that can be further tested
in refined experiments in mammalian models.
Introduction
Invasive aspergillosis (IA) is associated with considerable mor-
bidity and mortality in patients with compromised immunity
due to cancer chemotherapy, haematopoietic stem-cell transplan-
tation and solid organ transplantation.1-3 While A. fumigatus is
the most commonly cause of IA worldwide, A. terreus appears to
be frequently isolated in some institutions; e.g. the Medical Uni-
versity Hospital of Innsbruck, Austria, where approximately 15%
of all Aspergillus infections are caused by this pathogen, and the
M.D. Anderson Cancer Center in Houston, Texas, USA.4,5 In
general, mold infections remain difficult to manage because of
late diagnosis and complication during treatment due to drug
toxicities.6,7 Due to the high side effects caused by AMB such as
nephrotoxicity and infusional toxicity, lipid formulations of
AMB (L-AMB) are the reference formulation in the treatment of
invasive fungal infections. 8,9 In vivo and in vitro data indicate
that A. terreus isolates are intrinsically resistant to amphotericin B
(AMB) (MIC  2 mg/mL).10,11 The mechanisms involved in
AMB resistance are only partly elucidated and special focus has
been put on comparing cellular and metabolic differences in
AMB resistant isolates (ATR) to one susceptible isolate (ATS)
from the University of Milano (MIC of 0.5 mg/mL).12,13
Currently, 2 further A. terreus isolates from the USA have been
found to be susceptible against AMB.
The larvae of the greater wax moth, Galleria mellonella, have
been widely used as alternative models to evaluate the virulence
of microbial pathogens, including fungal pathogens, and to eval-
uate the efficacy of antimicrobial drugs.14,15 Of particular impor-
tance is the strong correlation to data obtained in murine
studies.16 Insects possess a cellular and humoral innate immune
system which bears similarities to innate immune response of ver-
tebrates.17 The cellular immune response is mediated by haemo-
cytes, which show strong structural and functional similarities
with mammalian phagocytes.18,19 Six different types of haemo-
cytes are defined in Galleria which are involved in phagocytosis,
encapsulation and melanization.20 Because their density is not
stable, examining changes in haemocyte populations can be used
to estimate immune responses to fungal infections or drug
treatment.14,21
The aim of this study was to establish and characterize a sim-
ple alternative in vivo model to study infections due to A. terreus.
Two ATR isolates and 3 ATS isolates were used to determine
differences in virulence potential and survival rates were
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correlated to physiological attributes and to in vitro AMB suscep-
tibility profile. The wax moth larvae were further used to evaluate
L-AMB efficacy in vivo and to compare outcome to in vitro sus-
ceptibility data. Additionally, the influence of L-AMB on haemo-
cyte density was determined.
Results
Killing of Galleria mellonella larvae by A. terreus isolates is
dose- and temperature dependent
To establish G. mellonella larvae as a model for A. terreus
infections, first, the optimal conidial dosage for virulence
studies was determined. Therefore, larvae were infected with
1 £ 105 – 1 £ 107 conidia per larva of the ATR isolate (T90)
and survival was monitored in parallel at 30C or 37C. As
expected, killing of the larvae depended on the number of
conidia injected and the incubation temperature (Fig. 1). Larvae
were killed significantly faster (p  0.05) when incubated at
37C compared to 30C at each inoculum density tested. Signifi-
cant difference between all 3 inocula was observed at both tem-
peratures. At 37C, all larvae infected with 1 £ 107 conidia died
within 72 h, while survival still reached 70% in those incubated
at 30C and it took 6 days before all larvae died. Infection with 1
£ 106 conidia at 37C resulted in 100% mortality at day 6, while
almost 50% survival was monitored at 30C. Lower inoculum
density (1 £ 105) resulted in 50% mortality at day 6 at 37C,
whereas larvae kept at 30C survived the infection (less than
10% mortality). Heat-inactivated conidia of T90 were not able
to cause mortality and survival was more than 80% after 120 h
incubation at either 30C or 37C (data not shown). The dose
and temperature dependency of this killing indicates that
G. mellonella larvae have the potential to serve as a non-vertebrate
animal host model for this group of Aspergilli.
A. terreus isolates exhibit different virulence potential
Distinct morphological variations were observed between the
ATR and ATS isolates. In order to see if the various isolates
exhibit differences in their virulence potential and to check if
this could be linked to morphological characteristics or AMB
susceptibility, the virulence potential of the 5 isolates was
compared. Significant differences in sur-
vival rates of larvae were determined,
when larvae were infected with 1 £ 107
conidia of each strain and incubated at
30C (Fig. 2). In summary, the ATR
strains (T9 and T90) showed lower viru-
lence potential compared to the ATS
strains (T77, 09-164 and 09-175), indi-
cated by significant differences in the
median survival of each strain, which was
60–72 h for the ATS strains and 96–
108 h for ATR isolates. T77, the isolate
exhibiting fastest killing of larvae, showed
significantly higher virulence potential
compared to T9 (p D 0.0310) and T90
(p D 0.0157), and isolate 09-175 displayed significantly higher
virulence compared to T9 (p D 0.0444) and T90 (p D 0.0214)
(Fig. 2). No significant difference compared to ATR isolates was
detected for the ATS isolate 09-164 (p > 0.05). As total mortal-
ity is reached earlier at 37C, we performed virulence studies
with 1 £ 106 conidia of each strain and incubated larvae at
37C (Fig. 4, solid lines). Difference in virulence potential was
less prominent at 37C than at 30C. Still, the difference is
reflected in the median survival of each strain. While larvae
infected with any of the ATS strains demonstrated a median sur-
vival of 72 h, for groups infected with ATR strains median sur-
vival was 84 h. The correlation between virulence potential and
physiological attributes of the infectious agent, or the size of the
infecting agent was already discussed before.22 Here too, higher
virulence potential correlated with higher germination rates and
increased growth rates in vitro (Figs. S1 and S2). For further
support, tissue sections of infected larvae embedded in paraffin
were performed and revealed that A. terreus is able to proliferate
within the host (Fig. 3). Additionally, faster growth ability, con-
nected with higher virulence potential, was obvious in vivo too,
as for the ATS strain T77 faster development of fungal hyphae
within the host tissue was observerd.
Figure 1. Dose- and temperature dependent mortality of G. mellonella larvae infected with A. ter-
reus. Ten larvae each were infected with different conidial concentrations of A. terreus (T90) and
incubated at 30C (A) or 37C (B), respectively. Experiments were performed at least 3 times.
Kaplan-Meyer curves represent one out of 3 experiments. Significant difference (p  0.05) was
observed within different inocula tested at each temperature.
Figure 2. Survival of G. mellonella larvae following inoculation with dif-
ferent A. terreus isolates. Larvae were infected with 20 mL IPS containing
1 £ 107 conidia of the respective A. terreus isolates and incubated at
30C. Survival was monitored every 24 h over 144 h (6 days). (ATR: T9
and T90; ATS: T77, 09-164 and 09-175). Kaplan-Meyer curves represent
one out of 3 experiments.
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AMB efficacy against A. terreus
infections in G. mellonella larvae
correlates with in vitro susceptibility
In vitro susceptibility of ATR and
ATS isolates against AMB and L-AMB
was determined with microbroth dilu-
tion assay according to the EUCAST
guildlines.23 No significant differences
in MICs between the different AMB for-
mulations were determined (data not
shown). Antifungal susceptibility testing
demonstrated a MIC range of 2 – 4 mg/
mL for both ATR isolates (geometric
mean of 3.125 mg/mL), while all 3
AMB susceptible strains had a MIC
range of 0.25 – 0.5 mg/mL (geometric
mean of 0.378 mg/mL). As L-AMB is
the therapeutic of choice, we used this
formulation for all in vivo assays. For
assessing AMB efficacy in vivo, a single
dose of L-AMB at a concentration of
0.5 mg and 5 mg per larvae, chosen according to the MIC values
of ATS strains plus a concentration 10 times higher, was admin-
istered to each larva, previously infected with 1 £ 106 conidia of
the respective A. terreus isolate and incubated at 37C. In addi-
tion to untreated and IPS controls, further control groups were
included receiving L-AMB (0.5 or 5 mg per larva) to rule out
Figure 3. Histopathology of G. mellonella infected with A. terreus ATS strain T77, and ATR strain T90.
Larvae were infected with IPS (left panel)), 1 £ 107 spores per larvae of ATS T77 (middle panel) and of
ATR T90 (right panel). Larvae were sacrificed at 12 h and 24 h after incubation at 37C, conserved in
formalin, embedded in paraffin. To identify the fungus more easily, tissue sections were stained with
Grocotts silver stain.
Figure 4. Ability of L-AMB to increase the time to death of G. mellonella challenged with ATR (A, C) and ATS strains (B, D, E). Larvae were infected with 1
£ 106 spores 2 h before L-AMB (0.5 mg and 5 mg per larvae) was administered and incubated at 37C. Survival was monitored every 24 h. Graphs repre-
sent one out of 3 single experiments. Results are significantly different (*p  0.05; **p  0.01; ***p  0.001; Mantel Cox test) to the untreated infected
larvae.
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putative toxic effects of L-AMB. Survival was not less than 80%
in any of the controls, indicating that L-AMB itself had no effect
on survival at the concentrations used (data not shown).
Treatment with L-AMB only showed success in the test
groups infected with ATS isolates (T77, 09-164, 09-175)
(Fig. 4B, D, and E), reflecting in vitro data. In groups that
received 5 mg of L-AMB, survival of larvae was significantly
(p  0.01) prolonged compared to control groups that received
IPS only. Although less pronounced, even the lower dose of
0.5 mg L-AMB per larva seemed to have a positive effect on sur-
vival, although statistically not significant. No significant increase
in survival due to L-AMB application could be detected for the 2
ATR isolates T9 and T90 (Fig. 4A, C).
A. terreus strains induce different cellular immune responses
in G. mellonella
To determine if differences in survival rates could be attrib-
uted to different killing activity of haemocytes against hyphae of
the different isolates, the extent of fungal damage induced by lar-
val haemocytes was measured by XTT-assay. Fungal damage
caused by isolated haemocytes was higher in the 2 ATR isolates
(T9 and T90) than in the ATS strains (T77, 09-164 and 09-175)
(data not shown). These results correspond to the data obtained
in virulence assays (Fig. 2), were ATS strains demonstrated
higher killing ability of larvae compared to ATR strains, which
might be due to less damage by haemocytes. Highest fungal dam-
age was measured for ATR isolate T90 (65.26%; SD § 12.36),
that also showed the lowest virulence potential. Interestingly, all
ATS strains exhibited 20% (SD§ 6.3) less damage caused by lar-
val haemocytes compared to the resistant strain T90. Further-
more, haemocyte densities of infected larvae were determined by
calculating the concentration of haemocytes per mL of haemo-
lymph. Haemocyte densities of infected larvae revealed compara-
ble numbers for larvae infected with ATR strains and the control,
while larvae infected with the ATS strains exhibited a decreased
density of circulating haemocytes in the haemolymph (Fig. 5).
This reduction was most prominent in larvae infected with the
ATS strain T77 (35.29%, SD § 10.94), suggesting that infection
with T77 induced haemocyte destruction.
Melanization is one of the first humoral responses of the larvae
and occurs quickly after infection.24 Larvae infected with ATS
strains showed higher melanization than ATR strains (Fig. 6).
Quantification of melanization revealed significant differences
(p < 0.05) in melanin accumulation between ATS and ATR
strains 24 h post infection, the effect being apparent at 37C,
resulting in a 3 times higher melanization rate for T77 than the
IPS control. ATR strains T9 and T90 showed only little differ-
ence in melanization compared to the IPS control (Fig. 6). These
data strengthen the hypothesis that A. terreus ATR and ATS
strains induce different cellular immune responses in G. mello-
nella, which might contribute to virulence potential.
Effect of L-AMB adiminstration on haemocyte density in
G. mellonella larvae
Previous work demonstrated that administration of caspofun-
gin to larvae primes the larval immune response by elevating
haemocyte density.21 L-AMB administration of 5 mg resulted in
a significant (p < 0.05) increase of 38.38%; SD § 5.14 in hae-
mocyte density 24 h after administration. Additionally, adminis-
tration of 0.5 mg of L-AMB demonstrated same increase in
haemocyte denisity after 24 h injection (35.61%; SD § 14).
Interestingly, no significant alterations in haemocyte densities
could be observed 4 h post-treatment (Fig. 7).
Discussion
The use of G. mellonella larvae to study the pathogenicity of
various microbial pathogens, including fungi, has been widely
reported in the recent years.15,25 Dose-dependent mortality
observed in this study was expected, as it has also been shown in
studies carried out with A. fumigatus.25 This, plus the obvious
development of hyphae inside the larval body, indicates that
A. terreus kills larvae through an active infection mechanism
rather than a merely physical effect of the injected conidia. Simi-
lar to what has been shown in 2 different mouse models and
embryonated chicken eggs, higher doses of A.terreus conidia were
necessary to cause same lethality compared to A. fumigatus in lar-
vae.26 The differences in virulence potential of A. terreus in G.
mellonella as observed here, correlate closely with previously pub-
lished data obtained with Balb/c mice, in which the ATS strain
T77 also exhibited higher pathogenicity than the ATR strain
T90.13 These findings make G. mellonella a valid model for A.
terreus infections.
Adaption of a fungal pathogen to different micro-environ-
mental stresses is necessary to allow germination and growth
within the host environment and strongly influences virulence.
Petraitis et al.22 demonstrated a correlation between virulence
Figure 5. Larval haemocyte densities in response to A. terreus infections.
Larvae were injected with a non lethal dose of different A. terreus spores
(ATR: T9, T90; ATS: T77, 09-164, 09-175) or IPS buffer and incubated at
30C for 48 h and haemocyte counts were carried out relative to the IPS
control. Results are significantly different (*p  0.05; **p  0.01;
Students t-test, 2 tail) to the IPS control.
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potential in vivo with species-dependent
differences in germination rate in vitro.
In contrast, investigating putative
differences in virulence potential of
A. fumigatus color mutants did not reveal
any correlation between faster germina-
tion and higher pathogenicity.25 Differ-
ent outcome of infection is also linked to
variable response of immune cells, such
as killing of intruding pathogens by
phagocytic cells, as shown in this study.
Reasons therefore could be explained by
variations in the outer layers of the iso-
lates or to a difference in resistance to
killing by reactive oxygen species.
Another factor contributing to viru-
lence is the secretion of secondary metab-
olites such as mycotoxins, that influence
host immune system or harm host tissue.
A well studied example is A. fumigatus
gliotoxin which is known to induce apo-
ptosis and prevents NF-kB activation by
inhibition of the proteasome and sup-
pression of angiogenesis. 27-31 Addition-
ally, fumagillin is also produced by
A. fumigatus during hyphal growth and has been identified as an
inhibitor of angiogenesis through a covalent interaction with
methionine aminopeptidase-2 and suppresses tumor growth.32,33
The production of gliotoxin and fumagillin was also proved in
infected G. mellonella larvae.31,34 A study by Lewis et al.35
detected gliotoxin in culture medium of A. terreus, but as we did
not test gliotoxin production, or any other secondary metabo-
lites, of the 5 different isolates we can only speculate its contribu-
tion to differences in virulence potential. The same effect may
account for the variable production of proteases by the ATR and
ATS strains. A linear relationship between the haemocyte density
and the survival rate of the larvae infected with Candida spp. was
demonstrated by Bergin et al.36 and these findings correlate with
the results presented here, demonstrating lower haemocyte den-
sity in larvae infected with ATS. Additionally, our results agree
with those presented previously,37 demonstrating correlation
between high increase in melanin and higher mortality rates in
larvae infected with different Klebsiella strains. Together, the
observed differences in resistance to haemocyte killing and mela-
nin production might explain the differences in virulence poten-
tial in addition to physiological attributes of the tested strains.
A. terreus isolates are known to show an intrinsic resistance to
AMB with MIC values 2 mg/mL.10,11,38 No clinical beakpoints
for AMB are defined for A. terreus species, but regarding the
EUCAST breakpoints for other Aspergillus spp, isolates with MIC
values >2 mg/mL are considered to be clinically resistant against
AMB.39 Data from in vitro studies correlate well with murine stud-
ies.12Only few A. terreus isolates have been found so far that showed
lower MIC values, making them AMB susceptible from a clinical
point of view. One of these isolates has already been tested in a
murine model, and treatment success was consistent with in vitro
data.12 In the larval model, the same outcome was shown for the 3
ATS strains and 2 ATR isolates, indicating that the larval model is a
useful tool to test for L-AMB efficacy in vivo, and could also be
employed with other fungal pathogens.
Administration of external agents into the insect haemocoel
was shown to result in an unspecific antimicrobial immune
response.21,34,40 A study by Kelly et al.21 demonstrated that
caspofungin administration primes the immune response of
G. mellonella larvae and induces a non-specific antimicrobial
response. Increased haemocyte numbers due to L-AMB seem not
to be enough to cure the infection, otherwise one would expect
Figure 6.Melanization of G. mellonella larvae infected with A. terreus. (A) Fold change of melanization
rate (OD 405nm) normalized to the IPS control at 30C (white) and 37C (gray). (B) Visual appearance
of larvae infected with different A. terreus strains at a dose of 1£ 107 spores after 24 h. Error bars rep-
resent standard deviation out of 3 independent experiments. (* p  0.05; *** p  0.001: 2 way
ANOVA).
Figure 7. Effect of L-AMB on the haemocyte density in G. mellonella. Hae-
mocyte density in larvae injected with IPS or L-AMB (0.5 or 5 mg/mL) and
incubated at 37C was assessed after 4 h and 24 h. Gray bars, 4 h; black
bars, 24 h. Results are significantly different (*p  0.05; **p  0.01;
Students t-test, 2 tail) to the IPS control.
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increased survival rates also in larvae infected with ATR strains.
Nevertheless, for ATS the positive effect on haemocyte numbers
might be an additional effect in prolonging survival.
In conclusion, this study demonstrates for the first time that the
G.mellonella larval model is useful to investigate the in vivo antifun-
gal efficacy of L-AMB against A. terreus isolates and it is also an
effective tool to screen for differences in virulence potential.
Immuno-stimulatory effects of antifungal agents should be taken
into consideration when interpreting results from in vivo treatment
studies employing Galleria, but as they were shown to be marginal
for AMB, G. mellonella larvae can be employed as a rapid, inexpen-
sive and reliable way to evaluate AMB efficacy in vivo.
Materials and methods
Fungal strains, growth conditions and susceptibility testing
All five A. terreus isolates tested were derived from clinical
specimens of either the University Hospital Innsbruck, Austria,
the University of Milan and Rome, Italy or the Stanford Univer-
sity, USA, ATS strains are named T77, 09-164 and 09-175 and
ATR strains T9 and T90. Species identification was performed
by sequencing the internal transcribed spacer region (ITS 3–4),
gene regions of b-tubulin, calmodulin, enolase and cytochrome
C. Fungi were grown on Aspergillus Complete Media41 for
7–14 days at 37C to obtain conidia. Minimum inhibitory con-
centration (MIC) of AMB and L-AMB were determined for all
strains following EUCAST guidelines 9.2.23 Antifungal suscepti-
bility testing was performed in triplicates on 3 separate occasions.
MIC was defined as the minimal concentration of AMB resulting
in complete growth inhibition.
Virulence assay and antifungal treatment studies
in G. mellonella
Sixth instar larvae of G. mellonella (Biologische Wurmzucht,
Langenzersdorf, Austria) were stored in wood shavings in the
dark at 18C prior to use. Larvae weighing 0.3 – 0.4 g were
selected for experimental use. Inoculum preparation, larval infec-
tion and monitoring of survival were carried out as described pre-
viously.42 Larvae injected with sterile insect physiological salin
(IPS; 150 mM NaCl, 5 mM KCl, 10 mM EDTA and 30 mM
sodium citrate in 0.1 M Tris–HCl, pH 6.9)18 and untouched
larvae served as controls. To utilize G. mellonella larvae as a
model for A. terreus infections to compare killing ability of differ-
ent A. terreus isolates, larvae were first infected with different con-
centrations of conidia (1£ 105, 1£ 106 and 1£ 107 conidia per
larva) of an A. terreus patient isolate. Survival was monitored in
parallel at 30C or 37C over 144 h. To determine different vir-
ulence potential of ATR and ATS, larvae were infected with 1 £
107 conidia per larvae and survival was monitored over 120 h at
30C. Additionally, survival rates were determine at 37C with
an infection dose of 1 £ 106 condida per larvae. To verify that
mortality ist due to active growth, larvae were infected with heat-
inactivated spores and survival was monitored at 30C and 37C.
To assess efficacy of L-AMB in vivo, larvae were infected with
1 £ 106 conidia per larva, and injected with 0.5 (1.6 mg/kg),
5 mg L-AMB (16.6 mg/kg) per larva, or IPS, respectively,
2 hours post-infection. For evaluation of antifungal treatment
larvae were incubated at 37C to make comparison to vertebrate
hosts possible.
Haemocyte isolation and determination of
haemocyte density
G. mellonella larvae were infected and treated as described
above. Haemocytes were isolated as described in 21 from 3 larvae
of each group, 4 h, 24 h or 48 h post injection of either patho-
gen or L-AMB. Larvae were incubated at 30C or 37C. Cell
density was determined by enumeration using a haemocytometer.
Determination of hyphal damage caused by haemocytes
A. terreus conidia (1£ 104 conidia per 100 mL) were incubated
in RPMI1640 at 37
C for 16 h to allow formation of hyphae, before
adding freshly isolated haemocytes in a ratio of 1:1 and further
incubation at 30C. Wells containing either fungus or haemocytes
alone served as controls. After 4 h haemocytes were lysed by ice-
cold 2% Triton X-100 and the viability of remaining hyphae was
quantified by the use of the In Vitro Toxicology Assay Kit, (XTT
assay; Sigma Aldrich) according to the manufacturers description.
The percentage of fungal damage was calculated with the following
formula: (1- [OD450 of fungi with haemocytes -OD450 of haemo-
cytes alone]/[OD450 of fungi alone])£ 100.
Histology of larvae
Infected larvae plus control larvae (injected with IPS), incu-
bated at 37C, were conserved as a whole in formalin for
10 days, embedded in paraffin, cut at 5 mm and stained with
Grocotts silver stain to detect fungal elements.43
Quantification of melanization
Larvae were infected with 1 £ 10£7 conidia per larva, and
incubated at either 30C or 37C, before haemolymph was col-
lected at 3 h and 24 h post infection. Haemolymph was diluted
1:10 in IPS buffer and 100 mL of each sample were placed in 96
well microdilution plates and quantification of melanization
assays were performed.14 Optical density of haemolymph from
infected larvae was normalized to that of control larvae.
Statistical analysis
All experiments were performed on at least 3 independent
occasions. Results are expressed as the mean § SD. Survival rates
were evaluated using Kaplan Meier survival curves and analyzed
with the log rank (Mantel-Cox) method utilizing GraphPad
Prism software. Further, Tukey Test (one way ANOVA) or Stu-
dents t-test were used to determine differences. Differences were
considered significant at *p  0.05.
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